Literature DB >> 35227736

Human cardiac myosin-binding protein C phosphorylation- and mutation-dependent structural dynamics monitored by time-resolved FRET.

Rhye-Samuel Kanassatega1, Thomas A Bunch1, Victoria C Lepak1, Christopher Wang1, Brett A Colson2.   

Abstract

Cardiac myosin-binding protein C (cMyBP-C) is a thick filament-associated protein of the sarcomere and a potential therapeutic target for treating contractile dysfunction in heart failure. Mimicking the structural dynamics of phosphorylated cMyBP-C by small-molecule drug binding could lead to therapies that modulate cMyBP-C conformational states, and thereby function, to improve contractility. We have developed a human cMyBP-C biosensor capable of detecting intramolecular structural changes due to phosphorylation and mutation. Using site-directed mutagenesis and time-resolved fluorescence resonance energy transfer (TR-FRET), we substituted cysteines in cMyBP-C N-terminal domains C0 through C2 (C0-C2) for thiol-reactive fluorescent probe labeling to examine C0-C2 structure. We identified a cysteine pair that upon donor-acceptor labeling reports phosphorylation-sensitive structural changes between the C1 domain and the tri-helix bundle of the M-domain that links C1 to C2. Phosphorylation reduced FRET efficiency by ~18%, corresponding to a ~11% increase in the distance between probes and a ~30% increase in disorder between them. The magnitude and precision of phosphorylation-mediated TR-FRET changes, as quantified by the Z'-factor, demonstrate the assay's potential for structure-based high-throughput screening of compounds for cMyBP-C-targeted therapies to improve cardiac performance in heart failure. Additionally, by probing C1's spatial positioning relative to the tri-helix bundle, these findings provide new molecular insight into the structural dynamics of phosphoregulation as well as mutations in cMyBP-C. Biosensor sensitivity to disease-relevant mutations in C0-C2 was demonstrated by examination of the hypertrophic cardiomyopathy mutation R282W. The results presented here support a screening platform to identify small molecules that regulate N-terminal cMyBP-C conformational states.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Biosensor; Cardiac myosin-binding protein C (cMyBP-C); Fluorescence lifetime; High-throughput screening (HTS); Phosphorylation; Protein kinase A (PKA); Time-resolved fluorescence resonance energy transfer (TR-FRET)

Mesh:

Substances:

Year:  2022        PMID: 35227736      PMCID: PMC9067379          DOI: 10.1016/j.yjmcc.2022.02.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.763


  51 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain.

Authors:  John M Squire; Pradeep K Luther; Carlo Knupp
Journal:  J Mol Biol       Date:  2003-08-15       Impact factor: 5.469

3.  Structural insight into unique cardiac myosin-binding protein-C motif: a partially folded domain.

Authors:  Jack W Howarth; Srinivas Ramisetti; Kristof Nolan; Sakthivel Sadayappan; Paul R Rosevear
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

4.  The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner.

Authors:  Justin F Shaffer; Robert W Kensler; Samantha P Harris
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

5.  Site-directed spectroscopy of cardiac myosin-binding protein C reveals effects of phosphorylation on protein structural dynamics.

Authors:  Brett A Colson; Andrew R Thompson; L Michel Espinoza-Fonseca; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-23       Impact factor: 11.205

6.  Fine mapping titin's C-zone: Matching cardiac myosin-binding protein C stripes with titin's super-repeats.

Authors:  Paola Tonino; Balazs Kiss; Jochen Gohlke; John E Smith; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2019-05-31       Impact factor: 5.000

7.  Identification of novel protein kinase A phosphorylation sites in the M-domain of human and murine cardiac myosin binding protein-C using mass spectrometry analysis.

Authors:  Weitao Jia; Justin F Shaffer; Samantha P Harris; Julie A Leary
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

8.  Revealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding.

Authors:  Alessio V Inchingolo; Samantha Beck Previs; Michael J Previs; David M Warshaw; Neil M Kad
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-15       Impact factor: 11.205

9.  A high-throughput fluorescence lifetime-based assay to detect binding of myosin-binding protein C to F-actin.

Authors:  Thomas A Bunch; Victoria C Lepak; Kellan M Bortz; Brett A Colson
Journal:  J Gen Physiol       Date:  2021-03-01       Impact factor: 4.086

10.  Structural and functional effects of myosin-binding protein-C phosphorylation in heart muscle are not mimicked by serine-to-aspartate substitutions.

Authors:  Thomas Kampourakis; Saraswathi Ponnam; Yin-Biao Sun; Ivanka Sevrieva; Malcolm Irving
Journal:  J Biol Chem       Date:  2018-08-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.